Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Evolus Inc

Start price
Target price
Perf. (%)
€3.13
14.12.20
-
83.45%
05.02.21

buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€69.50
14.12.20
-
14.12.21
-16.69%
19.04.21

buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€6.65
13.12.20
-
10.53%
14.01.21

Risky Investment
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€24.58
13.12.20
-
-10.62%
14.01.21

Could be worthwhile Investment >10% per year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.71
13.12.20
-
14.81%
14.01.21

buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€28.39
13.12.20
-
33.08%
14.01.21

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€3.06
13.12.20
-
13.12.21
1.50%
11.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
Formycon AG

Start price
Target price
Perf. (%)
€65.20
13.12.20
-
13.12.21
-19.94%
14.08.21

buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.79
13.12.20
-
13.12.21
-29.55%
14.12.21

Risky Investment
buy
Glycomimetics Inc.

Start price
Target price
Perf. (%)
€3.00
13.12.20
€4.20
13.12.21
-53.33%
14.12.21

buy
Tenax Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.80
13.12.20
€24.00
13.12.21
15.73%
14.12.21

buy
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€1.06
13.12.20
€1.20
13.12.21
47.17%
14.12.21

buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€142.00
13.12.20
€170.00
13.12.21
9.00%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€133.02
13.12.20
€165.00
13.12.21
12.43%
27.04.21

Curis Inc.

Start price
Target price
Perf. (%)
€6.35
13.12.20
-
13.12.21
37.01%
16.02.21

Below average Marketposition
Probably not worthwhile Investment
Significant cyclical dependencies
Little known brand
Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.66
13.12.20
-
13.12.21
143.95%
16.02.21

Probably not worthwhile Investment
Significant cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€46.63
12.12.20
€60.00
12.12.21
1.62%
27.08.21

PhaseBio Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.60
12.12.20
-
12.12.21
-42.22%
13.12.21

Probably not worthwhile Investment
buy
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.91
12.12.20
-
12.12.21
47.01%
09.01.21

Risky Investment
Acelrx Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€23.07
12.12.20
-
12.12.21
-5.77%
09.01.21

Risky Investment
Acer Therapeutics Inc

Start price
Target price
Perf. (%)
€1.92
12.12.20
-
12.12.21
2.60%
09.01.21

buy
Bayer AG

Start price
Target price
Perf. (%)
€46.63
12.12.20
-
12.12.21
17.67%
15.02.21

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€395.05
12.12.20
-
12.12.21
4.78%
09.01.21

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
CSL Ltd

Start price
Target price
Perf. (%)
€181.00
12.12.20
€100.00
12.12.21
11.93%
22.11.21

buy
Formycon AG

Start price
Target price
Perf. (%)
€65.20
12.12.20
-
12.12.21
-7.06%
11.03.21

Could be worthwhile Investment >10% per year